418 related articles for article (PubMed ID: 8255102)
1. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
2. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
8. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
9. [Soluble lymphocyte antigens in hematological diseases].
Yoneyama A; Higashihara M; Nakahara K
Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
[TBL] [Abstract][Full Text] [Related]
10. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
Marcante R; Cavedon G
Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy.
Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516
[TBL] [Abstract][Full Text] [Related]
16. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
17. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
[TBL] [Abstract][Full Text] [Related]
18. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
Xu J; Wang B
Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.
Raziuddin S; Sheikha A; Abu-Eshy S; al-Janadi M
Cancer; 1994 May; 73(9):2426-31. PubMed ID: 8168046
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
